AIDS Action Welcomes President Clinton's Call for HIV Preventative Vaccine in Next Decade
Clinton, Congress must make AIDS programs a budget priority
May 18, 1997
AIDS Action welcomes President Clinton?s call for the creation of a research center at the National Institutes of Health (NIH) to develop an HIV preventative vaccine within the next decade. President Clinton?s commitment to make the development of a vaccine for AIDS a - new national goal for science - is of vital importance to our national response to this dread disease. AIDS Action applauds the president for heeding the recommendations made last year by the 114-member Levine Committee, and by Nobel laureate Dr. David Baltimore. We are anxious to work with the Clinton administration and NIH officials to make an HIV preventative vaccine a reality. A preventative vaccine has the potential of curbing the further transmission of HIV, especially in Africa, South America, and Asia, where new and promising state-of-the-art treatments may never become available.
Unfortunately, President Clinton?s announcement comes on the heels of a budget agreement which offers no priority for biomedical or behavioral research, and the myriad other health care and social services programs that keep tens of thousands of people affected by HIV and AIDS alive and healthy. AIDS Action calls on President Clinton and the 105th Congress to make AIDS programs a priority, especially at a time when science has brought us unprecedented advancements in the treatment of HIV disease. Our national response to the AIDS epidemic is multi-faceted. AIDS Action will work with policymakers to ensure that all Americans affected by HIV and AIDS can continue to benefit from all the programs that make up the AIDS safety net.
The president?s call for a preventative vaccine is breathtaking in its scope. However, the extraordinary promise of his call can bear fruit only with concerted efforts across the federal government. These efforts will require strong support from the Clinton administration and Congress, leadership from the NIH and its Office of AIDS Research (OAR), and the watchful eye of AIDS Action and our partners.
(202) 986-1300 Ext. 3042
AIDS Action Council
This article was provided by AIDS Action Council.
The content on this page is free of advertiser influence and was produced by our editorial team. See our advertising policy.